4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-001329
Director sold 40,000 shares at an average $15.11 ($604,556)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal Director | 2023-01-03 | Sale | −23,382 | $15.19 | $355,067 | 1,222,381 | D: show line 1 in the form |
| Walker Neal Director | 2023-01-03 | Sale | −1,618 | $16.16 | $26,146 | 1,220,763 | D: show line 2 in the form |
| Walker Neal Director | 2023-01-04 | Sale | −15,000 | $14.89 | $223,343 | 1,205,763 | D: show line 3 in the form |
| Open-market sales · 40,000 sh · avg $15.11 · $604,556 | |||||||
Loading xslF345X03/doc4.xml…